# US 2017/0283793 A1 · Dna sequence and a mutator insertion sequence for increasing mutation rate

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0283793 A1
- Document ID: US20170283793A1
- Status: Published application
- Kind: A1
- Application number: 15/331,546
- Filed: 2016-10-21
- Published: 2017-10-05
- Earliest claimed: 2015-10-21
- Assignees: Academia Sinica
- Applicants: Academia Sinica
- Inventors: JUN-YI LEU; MICHAEL J. MCDONALD
- Web page: https://patentgrep.com/patent/US20170283793A1

## CPC

- C12N 15/1024: {In vivo mutagenesis using high mutation rate "mutator" host strains by inserting genetic material, e.g. encoding an error prone polymerase, disrupting a gene for mismatch repair}
- C12N 15/11: DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The invention relates to a DNA sequence for increase of a mutation rate over a specific region of DNA. Particularly, the invention provides a unique guanine nucleotide sequence and a mutator insertion sequence incorporated with the guanine nucleotide sequence and their applications in increasing a mutation rate.

## Claims

### Claim 1

A DNA sequence, comprising a short repeat nucleotide sequence of less than 20 guanine or adenine.

### Claim 2 (depends on 1)

The DNA sequence of claim 1, which comprises 20 (SEQ ID NO:1), 19 (SEQ ID NO:2), 18 (SEQ ID NO:3), 17 (SEQ ID NO:4), 16 (SEQ ID NO:5), 15 (SEQ ID NO:6), 14 (SEQ ID NO:7), 13 (SEQ ID NO:8), 12 (SEQ ID NO:9), 11 (SEQ ID NO:10) or 10 (SEQ ID NO:11) guanine nucleotides.

### Claim 3 (depends on 1)

The DNA sequence of claim 1, which comprises 11 (SEQ ID NO:10), 12 (SEQ ID NO:9), 13 (SEQ ID NO:8) or 14 (SEQ ID NO:7) guanine nucleotides.

### Claim 4 (depends on 1)

The DNA sequence of claim 1, which comprises 14 guanine nucleotides (SEQ ID NO: 7).

### Claim 5 (depends on 1)

The DNA sequence of claim 1, which further comprises one or more repeat sequences flanking one or two ends of the sequence.

### Claim 6 (depends on 5)

The DNA sequence of claim 5, wherein the repeat sequence is an inverted repeat, mirror repeat or direct repeat.

### Claim 7 (depends on 1)

A recombinant DNA sequence, comprising a polynucleotide sequence of interest and a DNA sequence of claim 1, wherein the DNA sequence is integrated into an upstream site of the polynucleotide sequence of interest.

### Claim 8 (depends on 1)

A mutator insertion sequence integrated with one or more the DNA sequence of claims 1.

### Claim 9 (depends on 8)

The mutator insertion sequence of claim 8, which comprises a ccdB gene and the DNA sequence, wherein the DNA sequence inserts into the ccdB gene at a site 30 bp from the end of the gene.

### Claim 10 (depends on 9)

The mutator insertion sequence of claim 9, wherein the ccdB gene is further followed by a DNA sequence comprising a short repeat nucleotide sequence of less than 20 guanine or adenine and another 30 bp of sequence encoding the last 10 amino acids of the ccdB protein, but using alternative codons.

### Claim 11 (depends on 8)

The mutator insertion sequence of claim 8, which further comprises one or more repeat sequences and optional one or more restriction enzyme sites flanking one or two ends of the open reading frame of interest of the mutator insertion sequence.

### Claim 12 (depends on 11)

The mutator insertion sequence of claim 11, wherein the repeat sequence is an inverted repeat, mirror repeat or direct repeat.

### Claim 13 (depends on 11)

The mutator insertion sequence of claim 11, wherein the restriction enzyme site is mme 1 restriction enzyme site.

### Claim 14 (depends on 11)

The mutator insertion sequence of claim 11, comprising a ccdB gene with an insertion of a G14 repeat sequence (SEQ ID NO: 7) into 30 bp from the end of the ccdB gene, then followed by a G14 repeat sequence (SEQ ID NO: 7) and a sequence of final 30 bp of the ccdB gene, wherein the mutator insertion sequence further comprises one or more additional repeat sequences and one or more restriction enzyme sites flanking the entire mutator insertion sequence.

### Claim 15 (depends on 14)

The mutator insertion sequence of claim 14, wherein the additional repeat sequence is an inverted repeat, mirror repeat or direct repeat.

### Claim 16 (depends on 11)

The mutator insertion sequence of claim 11, comprising a ccdB gene with an insertion of a G14 repeat sequence into 30 bp from the end of the ccdB gene, then followed by a G14 repeat sequence and a sequence of final 30 bp of the ccdB gene, wherein the mutator insertion sequence further comprises two inverted repeats or direct repeats and two restriction enzyme sites flanking the open reading frame of interest of the mutator insertion sequence.

### Claim 17 (depends on 14)

The mutator insertion sequence of claim 14, wherein the restriction enzyme site is AarI, AceIII, AloI, BaeI, Bbr7I, BbvI, BbvII, BccI, Bce83I, BceAI, BcgI, BciVI, BfiI, BinI, BplI, BsaXI, BscAI, BseMII, BseRI, BsgI, BsmI, BsmAI, BsmFI, Bsp24I, BspCNI, BspMI, BsrI, BsrDI, BstF5I, BtgZI, BtsI, CjeI, CjePI, EcuI, Eco32I, Eco57I, Eco57MI, Esp3I, FalI, FauI, FokI, GsuI, HaelV, HgaI, Hin4I, HphI, HpyAV, Ksp632I (EarI), MME1, MboII, MlyI, MnlI, PleI, PpiI, PsrI, RleAI, SapI, VapK32I, SfaNI, SspD5I, Sth132I, StsI, TaqII, TspDTI, TspGWI, TspRI, Tth111II, or an isoshizomer thereof.

### Claim 18 (depends on 8)

A vector comprising a mutator insertion sequence of claim 8.

### Claim 19 (depends on 18)

A host cell comprising the vector of claim 18.

### Claim 20 (depends on 1)

A method for increasing a mutation rate, comprising integrating a DNA sequence of claim 1.

### Claim 21 (depends on 8)

A method for increasing a mutation rate, comprising integrating a mutator insertion sequence of claim 8.
